Journal Scans
The Frequency, Manifestations, and Duration of Prolonged Cytopenias After First-Line Fludarabine Combination Chemotherapy
Persistence of Cytopenias After Fludarabine-Based Regimens
S Sill, D Carney, D Ritchie, M Wolf, D Westerman, HM Prince, H Januszewicz, JF Seymour
20100101
2010 Feb 1
Ann Oncol
The Frequency, Manifestations, and Duration of Prolonged Cytopenias After First-Line Fludarabine Combination Chemotherapy
Ann Oncol. 2010 Feb 1;21(2):331-334, S Sill, D Carney, D Ritchie, M Wolf, D Westerman, HM Prince, H Januszewicz, JF Seymour
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
The acute hematologic toxicities of fludarabine combination regimens in patients with low-grade lymphoid malignancies are well known and generally acceptable. Less information is available on the consequences of prolonged cytopenias. Gill et al report the incidence and effects of prolonged cytopenias in these patients. Records of 61 consecutive patients at Peter MacCallum Cancer Centre, in Victoria, Australia, were reviewed. All of the patients had been treated with frontline fludarabine plus cyclophosphamide...
